Among these 211At-labeled PSMA ligands, [211At]At-PSMA5 showed the most favorable biodistribution and planar images of [211At]At-PSMA5 revealed the tumor tissue at 3 and 24 h postinjection. The gene discussed is FOLH1; the disease is neoplasm.